Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs2091560 | chr4:165644137 | T/A | 5.56E-5 | 493 | 30.77 | 33.13 | 44.32 | KM Plot |
PRAD | rs2091561 | chr4:165644140 | C/T | 5.56E-5 | 493 | 30.77 | 33.13 | 44.32 | KM Plot |
PRAD | rs2091562 | chr4:165644262 | G/C | 5.56E-5 | 493 | 30.77 | 33.13 | 44.32 | KM Plot |
PRAD | rs2091563 | chr4:165644301 | A/T | 5.56E-5 | 493 | 30.77 | 33.13 | 44.32 | KM Plot |
PRAD | rs2099942 | chr22:18438314 | A/C | 1.17E-6 | 491 | 30.27 | 32.5 | 26.03 | KM Plot |
PRAD | rs2099943 | chr22:18438559 | A/G | 1.17E-6 | 490 | 30.53 | 32.5 | 26.03 | KM Plot |
PRAD | rs2099944 | chr22:18438578 | G/A | 1.17E-6 | 490 | 30.53 | 32.5 | 26.03 | KM Plot |
PRAD | rs2099945 | chr22:18438642 | G/C | 5.53E-6 | 490 | 30.8 | 32.43 | 26.2 | KM Plot |
PRAD | rs2126503 | chr19:53154820 | C/T | 1.38E-8 | 490 | 30.9 | 30.93 | 26.13 | KM Plot |
PRAD | rs2154375 | chr1:68281026 | T/C | 7.81E-5 | 491 | 30.93 | 29.23 | 36.87 | KM Plot |
PRAD | rs2174506 | chr1:31784363 | T/C | 8.26E-6 | 493 | 30.97 | 31.28 | 22.87 | KM Plot |
PRAD | rs218297 | chr6:108448566 | C/T | 4.11E-15 | 494 | 31.93 | 27.72 | 29.17 | KM Plot |
PRAD | rs2235563 | chr1:6724105 | A/G | 0.000136 | 494 | 30.37 | 31.13 | 29.7 | KM Plot |
PRAD | rs2235564 | chr1:6713114 | C/T | 5.22E-5 | 494 | 29.6 | 31.37 | 28.67 | KM Plot |
PRAD | rs2237124 | chr6:15490359 | A/G | 3.04E-5 | 494 | 30.8 | 31.4 | 29.25 | KM Plot |